These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens. Bettencourt P Front Immunol; 2020; 11():190. PubMed ID: 32153565 [No Abstract] [Full Text] [Related]
5. [Challenge of developing anti-parasite vaccines in the tropics]. Rogier C Med Trop (Mars); 2007 Aug; 67(4):328-34. PubMed ID: 17926789 [TBL] [Abstract][Full Text] [Related]
8. Protective immunity against malaria liver stage after vaccination with live parasites. Rénia L Parasite; 2008 Sep; 15(3):379-83. PubMed ID: 18814710 [TBL] [Abstract][Full Text] [Related]
9. Development of vaccines against human parasitic diseases: tools, current status and perspectives. Abath FG Expert Opin Investig Drugs; 2000 Feb; 9(2):301-10. PubMed ID: 11060678 [TBL] [Abstract][Full Text] [Related]
10. Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications. Gannavaram S; Dey R; Avishek K; Selvapandiyan A; Salotra P; Nakhasi HL Front Immunol; 2014; 5():241. PubMed ID: 24904589 [TBL] [Abstract][Full Text] [Related]
11. Live Vaccines Against Plasmodium Preerythrocytic Stages. Mac-Daniel L; Ménard R Methods Mol Biol; 2019; 2013():189-198. PubMed ID: 31267503 [TBL] [Abstract][Full Text] [Related]
12. [Approaches and problems in vaccine development against leishmaniasis]. Allahverdiyev A; Bağirova M; Cakir Koç R; Oztel ON; Elçıçek S; Ateş SC; Karaca TD Turkiye Parazitol Derg; 2010; 34(2):122-30. PubMed ID: 20597059 [TBL] [Abstract][Full Text] [Related]
13. Genetically modified live attenuated parasites as vaccines for leishmaniasis. Selvapandiyan A; Duncan R; Debrabant A; Lee N; Sreenivas G; Salotra P; Nakhasi HL Indian J Med Res; 2006 Mar; 123(3):455-66. PubMed ID: 16778323 [TBL] [Abstract][Full Text] [Related]
16. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers. Spring M; Murphy J; Nielsen R; Dowler M; Bennett JW; Zarling S; Williams J; de la Vega P; Ware L; Komisar J; Polhemus M; Richie TL; Epstein J; Tamminga C; Chuang I; Richie N; O'Neil M; Heppner DG; Healer J; O'Neill M; Smithers H; Finney OC; Mikolajczak SA; Wang R; Cowman A; Ockenhouse C; Krzych U; Kappe SH Vaccine; 2013 Oct; 31(43):4975-83. PubMed ID: 24029408 [TBL] [Abstract][Full Text] [Related]
17. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848 [TBL] [Abstract][Full Text] [Related]
18. Vaccination against malaria with live parasites. Rénia L; Grüner AC; Mauduit M; Snounou G Expert Rev Vaccines; 2006 Aug; 5(4):473-81. PubMed ID: 16989628 [TBL] [Abstract][Full Text] [Related]
19. Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. Weiss WR; Jiang CG PLoS One; 2012; 7(2):e31247. PubMed ID: 22355349 [TBL] [Abstract][Full Text] [Related]
20. Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites. Finney OC; Keitany GJ; Smithers H; Kaushansky A; Kappe S; Wang R Vaccine; 2014 Apr; 32(19):2135-8. PubMed ID: 24582635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]